Study of Safety, Tolerability, and Efficacy of Secukinumab in Subjects With Moderate to Severe Nail Psoriasis
Clinical trial NCT01807520 · COMPLETED
Trial details
- NCT number
- NCT01807520
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-20
- Primary completion
- 2017-01-03
- Enrollment
- 198
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.